Evidence map›Paper›PMID 38258838›Full record

ArticleSubstance use & addiction journal2024

"I'm on the Right Path": Exploring 1-Month Retention in a Homeless-Tailored Outpatient-Based Opioid Treatment Program.

Danielle R Fine, Natalia Critchley, Katherine Hart, Andrea Joyce, Nora Sporn, Jessie Gaeta, Joe Wright, Travis P Baggett, Gina Kruse

Open access · greenAbstract read
In one paragraph

Article in Substance use & addiction journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
4.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Danielle R FineMassachusetts General Hospital, Boston, MA, USA.ORCID 0000-0002-1970-3342
Natalia CritchleyMassachusetts General Hospital, Boston, MA, USA.
Katherine HartMassachusetts General Hospital, Boston, MA, USA.
Andrea JoyceMassachusetts General Hospital, Boston, MA, USA.
Nora SpornMassachusetts General Hospital, Boston, MA, USA.
Jessie GaetaBoston Health Care for the Homeless Program, Boston, MA, USA.
Joe WrightBoston Health Care for the Homeless Program, Boston, MA, USA.
Travis P BaggettMassachusetts General Hospital, Boston, MA, USA.
Gina KruseUniversity of Colorado School of Medicine, Aurora, CO, USA.ORCID 0000-0002-6681-220X
Massachusetts General Hospital · USBoston Health Care for the Homeless Program · USHarvard University · USUniversity of Colorado Denver · US

Funding

Career Development Program in Substance Use and Addiction MedicineK12DA043490 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI A EDEN EVINS, NANCY A RIGOTTI · 2017 to 2026
$4.7M
NIDA NIH HHS K12 DA043490
6 · The paper itself

Abstract

backgroundHomeless-tailored office-based opioid treatment (OBOT) programs have been developed to address the ongoing opioid overdose crisis, which disproportionately affects people experiencing homelessness. The objective of this study was to evaluate the facilitators of and barriers to retention in a homeless-tailored OBOT program.

methodsWe performed in-depth qualitative interviews with 24 homeless-experienced adults who newly enrolled in Boston Health Care for the Homeless Program's OBOT program from January 6, 2022 through January 5, 2023. We purposively sampled participants based on whether they were retained at 1 month (n = 12) or not (n = 12). We used an abductive analytic process, applying codes to the interview transcripts from an a priori analytic framework based on the Behavioral Model for Vulnerable Populations and supplementing with emergent codes as needed. We compared themes by participants' 1-month retention status to explore facilitators of and barriers to retention in OBOT care.

resultsThe average age was 41.9 years, 29.2% were female, 20.8% were Black, 58.3% were White, and 33.0% were Hispanic. Facilitators of retention common to many participants included the clinic experience, low-threshold model, clinic staff, and provision of comprehensive care. Among participants who were retained at 1-month, personal motivation, use of extended-release buprenorphine, and adequate buprenorphine efficacy were additional facilitators. Barriers to retention common to many participants included the clinic's surrounding environment, competing subsistence difficulties, and transportation difficulty. Among participants who were not retained at 1-month, opioid use severity, drug use in social networks, and inadequate buprenorphine efficacy represented additional barriers.

conclusionsWe identified several common determinants of OBOT retention among our homeless-experienced participants as well as some facilitators and barriers that differed by 1-month retention status. These divergent factors represent potential points of intervention to promote retention in homeless-tailored OBOT programs.

Indexed as

BuprenorphineIll-Housed PersonsAdultAnalgesics, OpioidFemaleHumansMaleOpiate Substitution TreatmentOutpatientsAnalgesics, OpioidBuprenorphinebuprenorphine treatmentopioid use disorderopioid use disorder treatmentpeople experiencing homelessnesstreatment retentionvulnerable populations

Identifiers

PMID38258838
PMCPMC11369761
OpenAlexW4390664759

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.